Recent Updates
Recently added Catalysts
BFLY Positive Sentiment

Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface

Key Takeaway: Bridge Neurotech and Butterfly Network have formed a partnership to develop a fully non-invasive brain-computer interface. This collaboration combines Bridge's innovative approach with Butterfly's expertise in ultrasound technology and AI. The partnership aims to advance the field of BCIs, making them more accessible and effective for users.

Market Sentiment Analysis

POSITIVE FACTORS

  • Partnership aims to advance non-invasive brain-computer interface technology.
  • Bridge Neurotech is emerging from stealth, indicating strong potential.
  • Butterfly Network's expertise in ultrasound and AI enhances the collaboration.

Full Press Release Details

BURLINGTON, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)---- $BFLY #BCI--Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced a research and development agreement through Butterfly Embedded™. Bridge was founded with a mission to make BCIs possible without

Frequently Asked Questions

What is the goal of the partnership between Bridge and Butterfly?

The partnership aims to develop a fully non-invasive brain-computer interface.

What technology does Butterfly Network specialize in?

Butterfly Network specializes in semiconductor-based ultrasound and AI.

What is Bridge Neurotech's mission?

Bridge Neurotech's mission is to make brain-computer interfaces possible without invasiveness.

What does the partnership leverage?

The partnership leverages Bridge's innovative approach and Butterfly's technological expertise.

Last updated: Oct 6, 2026